Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

A pulmonary score for assessing the severity of neonatal chronic lung disease.

Go back to Resources

A pulmonary score for assessing the severity of neonatal chronic lung disease.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Clinical trials referral resource. Multicenter phase I and II trials in adults with high-grade gliomas.

Go back to Resources

Clinical trials referral resource. Multicenter phase I and II trials in adults with high-grade gliomas.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Trial of calcium to prevent preeclampsia.

Go back to Resources

Trial of calcium to prevent preeclampsia.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

The effects of treatment noncompliance on power in a 2 x 2 factorial design.

Go back to Resources

The effects of treatment noncompliance on power in a 2 x 2 factorial design.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Tacrolimus ointment is effective for facial and intertriginous psoriasis.

Go back to Resources

Tacrolimus ointment is effective for facial and intertriginous psoriasis.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Should the definition of preeclampsia include a rise in diastolic blood pressure of >/=15 mm Hg to a level <90 mm Hg in association with proteinuria?

Go back to Resources

Should the definition of preeclampsia include a rise in diastolic blood pressure of >/=15 mm Hg to a level <90 mm Hg in association with proteinuria?

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Results of the cord blood transplantation (COBLT) study unrelated donor banking program.

Go back to Resources

Results of the cord blood transplantation (COBLT) study unrelated donor banking program.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Recommendations for collection and handling of specimens from group breast cancer clinical trials.

Go back to Resources

Recommendations for collection and handling of specimens from group breast cancer clinical trials.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Projected neurodegenerative disease mortality in the United States, 1990-2040.

Go back to Resources

Projected neurodegenerative disease mortality in the United States, 1990-2040.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Projected neurodegenerative disease mortality among minorities in the United States, 1990-2040.

Go back to Resources

Projected neurodegenerative disease mortality among minorities in the United States, 1990-2040.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Current page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions